Judith Carser

421 total citations
9 papers, 184 citations indexed

About

Judith Carser is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Judith Carser has authored 9 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Judith Carser's work include BRCA gene mutations in cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). Judith Carser is often cited by papers focused on BRCA gene mutations in cancer (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Melanoma and MAPK Pathways (3 papers). Judith Carser collaborates with scholars based in United Kingdom and Ireland. Judith Carser's co-authors include D. Paul Harkin, Richard D. Kennedy, Jennifer E. Quinn, Yvonne Summers, Colin R. James, W. Glenn McCluggage, Alistair Williams, Caroline O. Michie, Charlie Gourley and T F Lioe and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gynecologic Oncology.

In The Last Decade

Judith Carser

8 papers receiving 179 citations

Peers

Judith Carser

ONCOL

RM

GENET

MB

PHEOH

Vilius Rudaitis Lithuania

Anca Milea Canada

Maud Jonnaert United States

Janet R. Vos Netherlands

P.M.L.H. Vencken Netherlands

Kuniaki Nakayama Japan

Zimin Pan China

Jarosław Dębniak Poland

Marcin Jędryka Poland

Anthoula Koliadi Sweden

Vilius Rudaitis Lithuania

Judith Carser

106 ×1.2

ONCOL

101 ×1.3

RM

55 ×0.9

GENET

45 ×0.8

MB

11 ×0.4

PHEOH

Citations per year, relative to Judith Carser Judith Carser (= 1×) peers Vilius Rudaitis

Countries citing papers authored by Judith Carser

Since Specialization

Citations

This map shows the geographic impact of Judith Carser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Carser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Carser more than expected).

Fields of papers citing papers by Judith Carser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Carser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Carser. The network helps show where Judith Carser may publish in the future.

Co-authorship network of co-authors of Judith Carser

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Carser. A scholar is included among the top collaborators of Judith Carser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Carser. Judith Carser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Olsson‐Brown, Anna, et al.. (2025). Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence Study. Oncology and Therapy. 13(3). 649–665. 1 indexed citations

2.

Gupta, Avinash, Rubeta Matin, Alimu Dayimu, et al.. (2023). 1111P A randomised phase II study of intermittent versus continuous dosing of targeted therapy in patients with BRAFV600 mutant advanced melanoma (INTERIM). Annals of Oncology. 34. S669–S670.

3.

Carser, Judith, et al.. (2022). The use of tacrolimus in the management of checkpoint inhibitor immunotherapy-induced hepatitis. The Journal of the Royal College of Physicians of Edinburgh. 52(1). 20–23. 5 indexed citations

4.

Carser, Judith, Jennifer E. Quinn, Caroline O. Michie, et al.. (2011). BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer. Gynecologic Oncology. 123(3). 492–498. 52 indexed citations

5.

Quinn, Jennifer E., Judith Carser, Colin R. James, Richard D. Kennedy, & D. Paul Harkin. (2009). BRCA1 and implications for response to chemotherapy in ovarian cancer. Gynecologic Oncology. 113(1). 134–142. 67 indexed citations

6.

Carser, Judith, J. E. Quinn, Caroline O. Michie, et al.. (2009). BRCA1 protein expression as a predictor of outcome following chemotherapy in sporadic epithelial ovarian cancer (EOC). Journal of Clinical Oncology. 27(15_suppl). 5527–5527. 2 indexed citations

7.

Carser, Judith & Yvonne Summers. (2006). Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1(9). 1040–1041. 20 indexed citations

8.

Carser, Judith & Yvonne Summers. (2006). Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 1(9). 1040–1041. 15 indexed citations

9.

Graham, Lorraine, Stephen Wright, Gavin McClean, et al.. (2000). Could a low-cost audio-visual link be useful in rheumatology?. Journal of Telemedicine and Telecare. 6(1_suppl). 35–37. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact